Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Multi enzyme Cascade. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN117844726A reveals enzymatic vanillin synthesis. Discover cost-effective supply chain solutions and high-purity flavor intermediates for global industries.
Patent CN114426977A reveals a novel recombinant E. coli strain for D-pantolactone production, offering superior ee values and eliminating chemical waste for reliable pharmaceutical intermediate supply.
Patent CN118460491A reveals multi-enzyme cascade for D-Salvianic Acid. High purity, scalable process for pharmaceutical intermediates supply chain optimization.
Patent CN116287051B reveals a novel one-pot enzymatic route for Thienodolin. Discover cost-effective biosynthesis strategies for high-purity plant growth regulators.
Patent CN113005162A reveals a novel enzymatic route for NMN. Discover cost-effective, scalable production methods for high-purity nutritional ingredients.
Patent CN111321178B reveals a high-yield enzymatic route for L-2-aminobutanamide. Discover cost-effective manufacturing and supply chain advantages for API intermediates.
Patent CN118389613A reveals high-yield hydroxytyrosol synthesis. Offers cost reduction and supply chain reliability for food and pharma industries.
Patent CN118895266A reveals enzymatic synthesis of L-2-aminobutyric acid. Achieve >99% conversion with reduced environmental impact for levetiracetam production.
Patent CN113025544A reveals efficient whole-cell catalysis for L-phenyllactic acid. This method offers significant cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN113061630A reveals a multi-enzyme cascade for 4-HIL synthesis, offering significant cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing.
Patent CN113025546A reveals a novel multi-enzyme cascade for tyrosol production, offering significant cost reduction and green manufacturing advantages for pharmaceutical intermediates.
Advanced recombinant E. coli strain for D-pantoic acid production from valine. Offers cost-effective, scalable biosynthesis for reliable vitamin B5 precursor supply chains.
Patent CN110951799A reveals a novel whole-cell enzymatic route for high-purity (2S,3R)-p-methylsulfonylphenylserine, offering significant cost reduction and scalable green manufacturing for antibiotic intermediates.
Patent CN115725668B reveals high-purity L-vinylglycine via multi-enzyme cascade. Offers supply chain reliability and cost reduction in agrochemical intermediate manufacturing.
Patent CN117568302A reveals high-yield 2'-FL production. Cost-effective biocatalysis for infant nutrition supply chains.
Patent CN110951799B details a novel whole-cell enzymatic route for high-purity antibiotic intermediates, offering significant cost reduction and scalable manufacturing advantages.
Novel multi-enzyme cascade method for p-coumaric acid production offers high purity and cost efficiency for pharmaceutical and food industries.
Patent CN110452942B reveals a cost-effective immobilized enzyme method for D-ribulose, offering significant supply chain stability and reduced manufacturing costs for pharmaceutical intermediates.
Patent CN110423717A reveals a novel multi-enzyme cascade for D-pantolactone. This report analyzes cost reduction and supply chain advantages for vitamin B5 intermediate manufacturing.